Toronto, Canada

Venture-Backed, Alumni

Cyclica is focused on helping you navigate the drug discovery pipeline by assessing the safety and efficacy of drugs. Whether pre-clinical, clinical, or FDA approved, Cyclica can offer novel insight and analysis into your drugs’ effects using our in-house, drug-centric and structure-based bioinformatics platform.

By focusing on a small molecule structure and its polypharmacological profile, we distinguish ourselves with virtual screening technologies that are specific for a protein structure. We further augment our structural information with cognitive computing to drive our biophysical simulations.

Unlike deep-learning approaches that explore the limited space of established drug targets, our technology generates novel predictions that include conventional targets and beyond.

Cyclica's pre-clinical insights and in silico predictions improve current attrition rates of lead therapeutic compounds, improve patient outcomes with fewer side effects, and breathe life back into shelved therapeutics.


In the News